{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-26-000109","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2026-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.547615+00:00","generated_at":"2026-05-15T05:11:49.049993+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Danaher Q1 adj EPS $2.06 (+9.5%), revenue $6.0B (+3.5%), raises FY guidance","bullets":["Net earnings $1.0B, diluted EPS $1.45; adjusted EPS $2.06, up 9.5% YoY.","Revenue $6.0B (+3.5% reported, +0.5% core); operating cash flow $1.3B, free cash flow $1.1B.","Full-year 2026 adjusted EPS guidance raised to $8.35-$8.55 from $8.35-$8.50; core revenue reaffirmed 3%-6%.","Announces intent to acquire Masimo Corporation, a patient monitoring solutions firm; no deal terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-26-000109","json":"https://secwatch.observer/filing/0000313616-26-000109.json","markdown":"https://secwatch.observer/filing/0000313616-26-000109.md","text":"https://secwatch.observer/filing/0000313616-26-000109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000109/0000313616-26-000109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000109/dhr-20260421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:11:49.049993+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da1369120a476f92433c659e19f9d991b8c3f251","claim":"DANAHER CORP /DE/ reported First quarter 2026 results: revenue $6.0 billion, net income $1.0 billion, EPS $1.45 per diluted common share. Guidance raised.","evidence_excerpt":"were $1.0 billion, or $1.45 per diluted common share. • Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06. • Revenues increased 3.5% year-over-year to $6.0 billion and non-GAAP core revenue increased 0.5% year-over-year. • Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion. • Strong Q1 earnings performance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000109/0000313616-26-000109-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"First quarter 2026"},{"label":"Revenue","value":"$6.0 billion"},{"label":"Net income","value":"$1.0 billion"},{"label":"EPS","value":"$1.45 per diluted common share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}